Related Experiment Video

Updated: Jun 2, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

CHK1 as a Metabolic and Immunological Regulator: Implications for Cancer Therapy

Maria Franza1, Aurora Melfi1, Filippo Acconcia1

  • 1Department of Science, Roma Tre University, Rome, Italy.

Oncology Research
|June 1, 2026
PubMed

Insights

Checkpoint kinase 1 (CHK1) is vital for DNA damage response and cell cycle regulation. Its newly discovered roles in metabolism, immunity, and epigenetics offer new avenues for combinatorial cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Checkpoint kinase 1 (CHK1) is a key regulator of cell cycle checkpoints and the DNA damage response.
  • CHK1 acts as a critical mediator linking DNA damage detection to repair mechanisms.
  • Emerging evidence highlights CHK1's diverse roles beyond genomic integrity.

Purpose of the Study:

  • To analyze the structural and functional aspects of CHK1.
  • To focus on the non-canonical functions of CHK1.
  • To provide a foundation for next-generation combinatorial cancer therapies targeting CHK1.

Main Methods:

  • Review of existing literature on CHK1.
  • Analysis of CHK1's role in DNA damage response.
  • Exploration of CHK1's newly discovered cellular functions.

Main Results:

  • CHK1 monitors genomic integrity and coordinates DNA replication with metabolic resources.
  • CHK1 influences tumor immune surveillance, immune cell infiltration, and immune escape.
  • CHK1 is implicated in the regulation of differentiation and epigenetics.

Conclusions:

  • CHK1's pleiotropic roles make it a promising target for novel cancer therapies.
  • Targeting CHK1 offers potential for next-generation combinatorial therapies.
  • Further research into CHK1's non-canonical functions is crucial for therapeutic development.
Keywords:
Checkpoint kinase 1 (CHK1)cancer therapycheckpoint inhibitionglycolysisimmune evasionimmunomodulationmetabolismsynthetic lethality

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...